Immune cells that infiltrate gastrointestinal mucosa, as in inflammatory intestinal disease (IBD), secrete protumorigenic cytokines like TNF-α, IL-1, and IL-17 to increase NF-κB activity and to increase colon cancer risk [76]. This evidence concerns the gene IL17A and colonic neoplasm.